Multiple sclerosis is a chronic, autoimmune-mediated, demyelinating disease whose
pathogenesis remains to be defined. In past years, in consideration of a constantly growing …

Multiple sclerosis (MS) is a chronic and degrading autoimmune disorder mainly targeting the
central nervous system, leading to progressive neurodegeneration, demyelination, and …

Introduction Circulating microRNAs are promising biomarkers for multiple sclerosis (MS).
Our aim was to correlate serum microRNA levels with various magnetic resonance imaging …

Abstract Background and Aims Multiple sclerosis (MS) is a crippling, chronic, gender‐related
disease that causes burdens to individuals and society. China has a considerable and …

Objectives The objective of this study was to look at the clinical outcomes, and to determine
the proportion of children with visual recovery after the first demyelinating event of optic …

Disease-modifying therapies (DMTs) for multiple sclerosis (MS) reduce relapse frequency,
magnetic resonance imaging (MRI) activity, and slow disability progression. Numerous …

Background The global prevalence of aging individuals with multiple sclerosis (MS) is
increasing. This study aimed to assess the burden and trends of overall and smoking …

The number of ageing people with relapsing multiple sclerosis (RMS) is increasing. The
efficacy of disease-modifying therapies (DMTs) for RMS declines with age. Also, older …

Background Exercise in patients with multiple sclerosis (pwMS) found to improve symptom
management and regain function. Whether exercise lowers neurofilament light chain (NfL) …

Background Multiple sclerosis is a common inflammatory neurological disease among
young adults and is the tenth leading cause of the global burden of disease. Existing …